Clinicopathologic features among different viral epidemic outbreaks involving the skin

Priyadarsini, 2020, What can we learn from previous pandemics to reduce the frequency of emerging infectious diseases like COVID-19?, Glob Transit, 2, 202, 10.1016/j.glt.2020.09.003 Ellwanger, 2016, Emergent diseases in emergent countries: we must study viral ecology to prevent new epidemics, Braz J Infect Dis, 20, 403, 10.1016/j.bjid.2016.02.003 Billington, 2020, Developing vaccines for SARS-CoV-2 and future epidemics and pandemics: applying lessons from past outbreaks, Health Secur, 18, 241, 10.1089/hs.2020.0043 Petersen, 2020, Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics, Lancet Infect Dis, 20, e238, 10.1016/S1473-3099(20)30484-9 Adhanom T. WHO Director-General's opening remarks at the media briefing on COVID-19—11 March 2020. World Health Organization. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed May 2, 2021. European Centre for Disease Prevention and Control. Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK—sixth update 2020, 20 March 2020. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.pdf. Accessed May 2, 2021. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) 2019. Available at: https://www.cdc.gov/coronavirus/2019-ncov/index.html. Accessed May 2, 2021. Coronavirus Resource Center of the John Hopkins University. COVID-19 Dashboard by the Center for Systems Science for Engineering (CSSE) at Johns Hopkins University (JHU). Available at: https://coronavirus.jhu.edu/map.html. Accessed May 2, 2021. Keighley, 2015, Viral exanthems, Curr Opin Infect Dis, 28, 139, 10.1097/QCO.0000000000000145 Criado, 2020, Lessons from dermatology about inflammatory responses in Covid-19, Rev Med Virol, 30, e2130, 10.1002/rmv.2130 Drago, 2017, Contemporary infectious exanthems: an update, Future Microbiol, 12, 171, 10.2217/fmb-2016-0147 Peeri, 2020, The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?, Int J Epidemiol, 49, 717, 10.1093/ije/dyaa033 Petrosillo, 2020, COVID-19, SARS and MERS: are they closely related?, Clin Microbiol Infect, 26, 729, 10.1016/j.cmi.2020.03.026 Contini, 2020, The novel zoonotic COVID-19 pandemic: an expected global health concern, J Infect Dev Ctries, 14, 254, 10.3855/jidc.12671 Rongioletti, 2020, SARS-CoV, Mers-CoV and COVID-19: what differences from a dermatological viewpoint?, J Eur Acad Dermatol Venereol, 34, e581, 10.1111/jdv.16738 Xie, 2020, Insight into 2019 novel coronavirus—an updated interim review and lessons from SARS-CoV and MERS-CoV, Int J Infect Dis, 94, 119, 10.1016/j.ijid.2020.03.071 Yu, 2020, Emerging coronaviruses: genome structure, replication, and pathogenesis, J Med Virol, 92, 418, 10.1002/jmv.25681 2020, The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, Nat Microbiol, 5, 536, 10.1038/s41564-020-0695-z Chan, 2020, Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan, Emerg Microbes Infect, 9, 221, 10.1080/22221751.2020.1719902 Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir Med, 8, 420, 10.1016/S2213-2600(20)30076-X Kakodkar, 2020, A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19), Cureus, 12, e7560 Qin, 2020, Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin Infect Dis, 71, 762, 10.1093/cid/ciaa248 World Health Organization. Weekly epidemiological update. Available at. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200928-weekly-epi-update.pdf?sfvrsn=9e354665_6. Accessed May 2, 2021. Matar, 2020, Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature, J Eur Acad Dermatol Venereol, 34, e686, 10.1111/jdv.16775 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Recalcati, 2020, Cutaneous manifestations in COVID-19: a first perspective, J Eur Acad Dermatol Venereol, 34, e212 Galván Casas, 2020, Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases, Br J Dermatol, 183, 71, 10.1111/bjd.19163 Zhao, 2020, COVID-19 and cutaneous manifestations: a systematic review, J Eur Acad Dermatol Venereol, 34, 2505, 10.1111/jdv.16778 Freeman, 2020, The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries, J Am Acad Dermatol, 83, 1118, 10.1016/j.jaad.2020.06.1016 Wollina, 2020, Cutaneous signs in COVID-19 patients: a review, Dermatol Ther, 33, e13549, 10.1111/dth.13549 Criado, 2020, Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms, Inflamm Res, 69, 745, 10.1007/s00011-020-01370-w Marzano, 2020, Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue, Br J Dermatol, 183, 431, 10.1111/bjd.19264 Kaya, 2020, Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: review of the literature, Dermatopathology (Basel), 7, 3, 10.3390/dermatopathology7010002 Seirafianpour, 2020, Cutaneous manifestations and considerations in COVID-19 pandemic: a systematic review, Dermatol Ther, 33, e13986, 10.1111/dth.13986 Riphagen, 2020, Hyperinflammatory shock in children during COVID-19 pandemic, Lancet, 395, 1607, 10.1016/S0140-6736(20)31094-1 Bapst, 2020, Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme, BMJ Case Rep, 13, 10.1136/bcr-2020-236986 Verdoni, 2020, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet, 395, 1771, 10.1016/S0140-6736(20)31103-X Recalcati, 2020, Acral cutaneous lesions in the time of COVID-19, J Eur Acad Dermatol Venereol, 34, e346, 10.1111/jdv.16533 Piccolo, 2020, Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients, Eur Acad Dermatol Venereol, 34, e291, 10.1111/jdv.16526 de Masson, 2020, Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France, J Am Acad Dermatol, 83, 667, 10.1016/j.jaad.2020.04.161 El Hachem, 2020, A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection, J Eur Acad Dermatol Venereol, 34, 2620, 10.1111/jdv.16682 Locatelli, 2020, Histologic features of long-lasting chilblain-like lesions in a pediatric COVID-19 patient, J Eur Acad Dermatol Venereol, 34, e365, 10.1111/jdv.16617 Kolivras, 2020, Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings, JAAD Case Rep, 18, 489, 10.1016/j.jdcr.2020.04.011 Hamming, 2004, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus., J Pathol, 203, 631, 10.1002/path.1570 Colmenero, 2020, SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases, Br J Dermatol, 183, 729, 10.1111/bjd.19327 Roca-Ginés, 2020, Assessment of acute acral lesions in a case series of children and adolescents during the COVID-19 pandemic, JAMA Dermatol, 156, 992, 10.1001/jamadermatol.2020.2340 Caselli, 2020, No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain, Br J Dermatol, 183, 784, 10.1111/bjd.19349 Herman, 2020, Evaluation of chilblains as a manifestation of the COVID-19 pandemic, JAMA Dermatol, 156, 998, 10.1001/jamadermatol.2020.2368 Docampo-Simón, 2020, Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review, J Eur Acad Dermatol Venereol, 34, e445, 10.1111/jdv.16665 Llamas-Velasco, 2020, Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient, Br J Dermatol, 183, 591, 10.1111/bjd.19222 Suarez-Valle, 2020, Acro-ischaemia in hospitalized COVID-19 patients, J Eur Acad Dermatol Venereol, 34, e455, 10.1111/jdv.16592 Balestri, 2020, Late onset of acral necrosis after SARS-CoV-2 infection resolution, J Eur Acad Dermatol Venereol, 34, e448, 10.1111/jdv.16668 Andersen, 2020, [Acral ischaemia with multiple microthromboses and imminent gangrene in a 73-year-old woman with COVID-19], Ugeskr Laeger, 182 Caputo, 2020, A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19, J Eur Acad Dermatol Venereol, 34, e579, 10.1111/jdv.16737 Magro, 2020, Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases, Transl Res, 220, 1, 10.1016/j.trsl.2020.04.007 Zhang, 2020, Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients, J Thromb Thrombolysis, 50, 580, 10.1007/s11239-020-02182-9 Zhang, 2020, [Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia], Zhonghua Xue Ye Xue Za Zhi, 41, 302 Schnapp, 2020, Introductory histopathological findings may shed light on COVID-19 paediatric hyperinflammatory shock syndrome, J Eur Acad Dermatol Venereol, 34, e665, 10.1111/jdv.16749 Fernandez-Nieto, 2020, Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital, Clin Exp Dermatol, 45, 872, 10.1111/ced.14277 Llamas-Velasco, 2020, Comment on ‘Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital.’ Pseudo herpetic Grover disease seems to appear in patients with COVID-19 infection, Clin Exp Dermatol, 45, 896, 10.1111/ced.14305 Mahé, 2020, Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not ‘varicella-like.’, J Eur Acad Dermatol Venereol, 34, e559, 10.1111/jdv.16706 Xue, 2021, High expression of ACE2 on keratinocytes reveals skin as a potential target for SARS-CoV-2, J Invest Dermatol, 141, 206, 10.1016/j.jid.2020.05.087 Jamiolkowski, 2020, SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report, Lancet, 396, 598, 10.1016/S0140-6736(20)31754-2 Santonja, 2020, COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient, Br J Dermatol, 183, 778, 10.1111/bjd.19338 Shanks, 2015, Insights from unusual aspects of the 1918 influenza pandemic, Travel Med Infect Dis, 13, 217, 10.1016/j.tmaid.2015.05.001 Murray, 2006, Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis, Lancet, 368, 2211, 10.1016/S0140-6736(06)69895-4 Smith, 2009, Dating the emergence of pandemic influenza viruses, Proc Natl Acad Sci U S A, 106, 11709, 10.1073/pnas.0904991106 Worobey, 2014, Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus, Proc Natl Acad Sci U S A, 111, 8107, 10.1073/pnas.1324197111 Shanks, 2012, Pathogenic responses among young adults during the 1918 influenza pandemic, Emerg Infect Dis, 18, 201, 10.3201/eid1802.102042 Gagnon, 2015, Is antigenic sin always “original?” Re-examining the evidence regarding circulation of a human H1 influenza virus immediately prior to the 1918 Spanish Flu, PLoS Pathog, 11, 10.1371/journal.ppat.1004615 Skowronski, 2010, Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada, PLoS Med, 7, 10.1371/journal.pmed.1000258 Duque, 2011, Clinical manifestations of pandemic (H1N1) 2009 in the ambulatory setting, J Infect Dev Ctries, 5, 658, 10.3855/jidc.2024 Muir, 1919, Observations on influenza and its complications, BMJ, 1, 3, 10.1136/bmj.1.3027.3 Abrahams, 1919, Influenzo-pneumococcal and influenzo-streptococcal septicaemia: epidemic influenzal “pneumonia” of highly fatal type and its relation to “purulent bronchitis.”, Lancet, 193, 1, 10.1016/S0140-6736(01)22115-1 Macpherson, 1923, History of the Great War based on official documents. Medical services, Diseases of the war, 2, 1 Taubenberger, 2008, The pathology of influenza virus infections, Annu Rev Pathol, 3, 499, 10.1146/annurev.pathmechdis.3.121806.154316 Brem, 1918, Pandemic influenza and secondary pneumonia at camp Fremont, Calif, JAMA, 71, 2138, 10.1001/jama.1918.26020520007010b Miah, 2021, Coinfection, coepidemics of COVID-19, and dengue in dengue-endemic countries: a serious health concern, J Med Virol, 93, 161, 10.1002/jmv.26269 Joob, 2020, COVID-19 can present with a rash and be mistaken for dengue, J Am Acad Dermatol, 82, e177, 10.1016/j.jaad.2020.03.036 Lokida, 2020, Diagnosis of COVID-19 in a dengue-endemic area, Am J Trop Med Hyg, 103, 1220, 10.4269/ajtmh.20-0676 Bastos, 2018, Silva Junior GBD. Thrombotic thrombocytopenic purpura associated with dengue and chikungunya virus coinfection: case report during an epidemic period, Rev Inst Med Trop Sao Paulo, 60, e48, 10.1590/s1678-9946201860048 Epelboin, 2017, Fatal case of chikungunya and concomitant thrombotic thrombocytopenic purpura in French Guiana during air flight medical evacuation, J Travel Med, 24, 10.1093/jtm/tax028 Deepahjali, 2015, Dengue virus infection triggering thrombotic thrombocytopenic purpura in pregnancy, Am J Trop Med Hyg, 93, 1028, 10.4269/ajtmh.15-0326 Ferreira, 2005, Manifestações neurológicas de dengue: estudo de 41 casos [Neurological manifestations of dengue: study of 41 cases], Arq Neuropsiquiatr, 63, 488, 10.1590/S0004-282X2005000300023 Teixeira, 2009, Diagnosis and management of dengue, BMJ, 339, b4338, 10.1136/bmj.b4338 Albuquerque, 2009, Dengue and aplastic anemia: a rare association, Travel Med Infect Dis, 7, 118, 10.1016/j.tmaid.2009.01.001 Ehelepolar, 2016, A dengue infection without bleeding manifestation in an adult with immune thrombocytopenic purpura, Trop Med Health, 44, 36, 10.1186/s41182-016-0036-3 Itoda, 2006, Clinical features of 62 imported cases of dengue fever in Japan, Am J Trop Med Hyg, 75, 470, 10.4269/ajtmh.2006.75.470 Azfar, 2012, Cutaneous manifestations in patients of dengue fever, J Pak Assoc Dermatol, 22, 320 Thomas, 2010, Mucocutaneous manifestations of dengue fever, Indian J Dermatol, 55, 79, 10.4103/0019-5154.60359 Chadwick, 2006, Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features: application of logistic regression analysis, J Clin Virol, 35, 147, 10.1016/j.jcv.2005.06.002 Mahboob, 2012, Dermatological manifestations of dengue fever, J Ayub Med Coll Abbottabad, 24, 52 Huang, 2016, Clinical significance of skin rash in dengue fever: a focus on discomfort, complications, and disease outcome, Asian Pac J Trop Med, 9, 713, 10.1016/j.apjtm.2016.05.013 Martyn-Simmons, 2007, A florid skin rash in a returning traveller, Clin Exp Dermatol, 32, 779, 10.1111/j.1365-2230.2007.02419.x Wu, 2000, Human skin Langerhans cells are targets of dengue virus infection, Nat Med, 6, 816, 10.1038/77553 Saadiah, 2008, Skin histopathology and immunopathology are not of prognostic value in dengue haemorrhagic fever, Br J Dermatol, 158, 836, 10.1111/j.1365-2133.2008.08459.x Booth, 2011, Systemic infections mimicking thrombotic thrombocytopenic purpura, Am J Hematol, 86, 743, 10.1002/ajh.22091 Patterson, 2016, Dengue, zika and chikungunya: emerging arboviruses in the new world, West J Emerg Med, 17, 671, 10.5811/westjem.2016.9.30904 Rezza, 2007, Infection with chikungunya virus in Italy: an outbreak in a temperate region, Lancet, 370, 1840, 10.1016/S0140-6736(07)61779-6 Haby, 2018, Prevalence of asymptomatic zika virus infection: a systematic review, Bull World Health Organ, 96, 402, 10.2471/BLT.17.201541 Kumar, 2017, Cutaneous manifestations of chikungunya fever: observations from an outbreak at a tertiary care hospital in southeast Rajasthan, India, Indian Dermatol Online J, 8, 336, 10.4103/idoj.IDOJ_429_16 Kumar, 2019, Experience of perinatal and neonatal chikungunya virus (CHIKV) infection in a tertiary care neonatal centre during outbreak in north India in 2016: a case series, J Trop Pediatr, 65, 169, 10.1093/tropej/fmy032 Barr, 2019, Chikungunya in infants and children: is pathogenesis increasing?, Viruses, 11, 294, 10.3390/v11030294 Muñoz, 2016, Atypical mucocutaneous manifestations in neonates and infants with chikungunya fever in the municipalities of Cúcuta, Los Patios and Villa del Rosario, Norte de Santander, Colombia, 2014., Biomedica, 36, 368 Inamadar, 2008, Cutaneous manifestations of chikungunya fever: observations made during a recent outbreak in south India, Int J Dermatol, 47, 154, 10.1111/j.1365-4632.2008.03478.x Townson, 2008, Resurgence of chikungunya, Trans R Soc Trop Med Hyg, 102, 308, 10.1016/j.trstmh.2007.11.013 Riyaz, 2010, Cutaneous manifestations of chikungunya during a recent epidemic in Clicut, north Kerala, south India, Indian J Dermatol Venereol Leprol, 76, 671, 10.4103/0378-6323.72466 Seetharam, 2012, Cutaneous manifestations of chikungunya fever, Indian Pediatr, 49, 51, 10.1007/s13312-012-0007-7 Shivakumar, 2007, Unusual facial melanosis in viral fever, Indian J Dermatol, 52, 116, 10.4103/0019-5154.33295 Fernandes, 2019, Immunoglobulin therapy in a patient with severe chikungunya fever and vesiculobullous lesions, Front Immunol, 10, 1498, 10.3389/fimmu.2019.01498 El Sayed, 2008, Chikungunya associated with cutaneous ulcerations, Clin Exp Dermatol, 33, 463, 10.1111/j.1365-2230.2008.02722.x Singal, 2018, Isolated nail pigmentation associated with chikungunya: a hitherto unreported manifestation, Skin Appendage Disord, 4, 312, 10.1159/000485853 Matusali, 2019, Tropism of the chikungunya virus., Viruses, 11, 175, 10.3390/v11020175 Kumar, 2017, Chikungunya fever presenting as life threatening thrombotic thrombocytopenic purpura, J Assoc Physicians India, 11765, 96 Spiteri, 2017, The European Zika Surveillance Network. Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017, Euro Surveill, 22, 17, 10.2807/1560-7917.ES.2017.22.41.17-00254 Counotte, 2018, Sexual transmission of Zika virus and other flaviviruses: a living systematic review, PLoS Med, 15, 10.1371/journal.pmed.1002611 Hastings, 2017, Zika virus and sexual transmission: a new route of transmission for mosquito-borne flaviviruses, Yale J Biol Med, 90, 325 Tang, 2019, Implication of sexual transmission of Zika on dengue and Zika outbreaks, Math Biosci Eng, 16, 5092, 10.3934/mbe.2019256 Kim, 2018, Investigating the sexual transmission of Zika virus, Lancet Glob Health, 6, e24, 10.1016/S2214-109X(17)30419-9 Farahnik, 2016, Cutaneous manifestations of the Zika virus, J Am Acad Dermatol, 74, 1286, 10.1016/j.jaad.2016.02.1232 Joob, 2020, Cutaneous manifestations of Zika, J Cutan Med Surg, 24, 220, 10.1177/1203475419893937 Ramos, 2020, Cutaneous manifestations of Zika in Peru, J Cutan Med Surg, 24, 33, 10.1177/1203475419878160 Paniz-Mondolfi, 2019, Cutaneous features of Zika virus infection: a clinicopathological overview, Clin Exp Dermatol, 44, 13, 10.1111/ced.13793 Nkoghe, 2012, Cutaneous manifestations of filovirus infections, Int J Dermatol, 51, 1037, 10.1111/j.1365-4632.2011.05379.x Gates, 2015, The next epidemic—lessons from Ebola, N Engl J Med, 372, 1381, 10.1056/NEJMp1502918 Coltart, 2017, The Ebola outbreak, 2013-2016: old lessons for new epidemics, Philos Trans R Soc Lond B Biol Sci, 372, 10.1098/rstb.2016.0297 Kucharski, 2014, Case fatality rate for Ebola virus disease in west Africa, Lancet, 384, 1260, 10.1016/S0140-6736(14)61706-2 Leroy, 2005, Fruit bats as reservoirs of Ebola virus, Nature, 438, 575, 10.1038/438575a Blattner, 2015, Cutaneous manifestations of the Ebola virus, Dermatol Online J, 21, 10.5070/D3213025964 Bwaka, 1999, Ebola hemorrhagic fever in Kikwit, Democratic Republic of Congo: clinical observations in 103 patients, J Infect Dis, 1, S1, 10.1086/514308 Martines, 2015, Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses, J Pathol, 235, 153, 10.1002/path.4456 Zaki, 1999, A novel immunohistochemical assay for detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever, J Infect Dis, 179, S36, 10.1086/514319 Ling, 2020, COVID-19: a critical care perspective informed by lessons learnt from other viral epidemics, Anaesth Crit Care Pain Med, 39, 163, 10.1016/j.accpm.2020.02.002